SUMMARY
This review summarises the most recent data in support of the role of the mitochondrial permeability transition pore (mPTP) in ischaemia-reperfusion injury, how anaesthetic agents interact with this molecular channel, and the relevance this holds for current anaesthetic practice. Ischaemia results in damage to the electron transport chain of enzymes and sets into play the assembly of a non-specific mega-channel (the mPTP) that transgresses the inner mitochondrial membrane. During reperfusion, uncontrolled opening of the mPTP causes widespread depolarisation of the inner mitochondrial membrane, hydrolysis of ATP, mitochondrial rupture and eventual necrotic cell death. Similarly, transient opening of the mPTP during less substantial ischaemia leads to differential swelling of the intermembrane space compared to the mitochondrial matrix, rupture of the outer mitochondrial membrane and release of pro-apoptotic factors into the cytosol. Recent data suggests that cellular protection from volatile anaesthetic agents follows specific downstream interactions with this molecular channel that are initiated early during anaesthesia. Intravenous anaesthetic agents also prevent the opening of the mPTP during reperfusion. Although by dissimilar mechanisms, both volatiles and propofol promote cell survival by preventing uncontrolled opening of the mPTP after ischaemia. It is now considered that anaestheticinduced closure of the mPTP is the underlying effector mechanism that is responsible for the cytoprotection previously demonstrated in clinical studies investigating anaesthetic-mediated cardiac and neuroprotection. Manipulation of mPTP function offers a novel means of preventing ischaemic cell injury. Anaesthetic agents occupy a unique niche in the pharmacological armamentarium available for use in preventing cell death following ischaemia-reperfusion injury.
observed changes in mitochondrial permeability. Furthermore, this channel is intrinsic in the initiation of both cellular necrotic and apoptotic pathways that are seen to follow from ischaemia-reperfusion. This review therefore aims to summarise the most recent data in support of the mPTP, how anaesthetic agents have been determined to interact with this molecular channel during reperfusion-mediated ischaemic cell death, and the relevance this holds to current anaesthetic practice.
METHODS
Comprehensive searches were conducted without language restriction. Studies and reviews were identified from MEDLINE through the PubMED database from inception to June 2011. The search terms (including truncations) were: "mitochondrial permeability transition($) AND necrosis OR apoptosis", "volatile an(a)esth$ AND mitochondrial permeability transition($) (AND necrosis OR apoptosis)", "halothane OR enflurane OR sevoflurane OR desflurane OR propofol AND mitochondrial permeability transition($) (AND necrosis OR apoptosis)", "isch(a)emia reperfusion injury AND mitochondrial permeability transition($)", "volatile an(a)esthe$ AND isch(a)emia reperfusion injury", "halothane OR enflurane OR isoflurane OR sevoflurane OR desflurane OR propofol AND ischaemia reperfusion injury", "clinical study AND mitochondrial permeability transition($)", "volatile an(a)esth$ AND pre OR postcondition($) (AND clinical study)", "propofol AND pre OR postcondition($) (AND clinical study)", "halothane OR enflurane OR isoflurane OR sevoflurane OR desflurane OR propofol AND myocardial OR neuro OR renal OR hepatic protection (AND clinical study)".
MECHANISTIC OVERVIEW OF MITOCHONDRIAL PERMEABILITY TRANSITION Necrotic cell death
In specific circumstances, such as that seen during ischaemia-reperfusion, mitochondrial calcium (Ca 2+ ) uptake can switch from what is normally a physiological regulatory mechanism to a potentially harmful process responsible for triggering a cascade of signals that leads to overt cell death. The morphological features of necrotic cell death are characteristic. They feature a gain in cell volume (oncosis) and swelling of organelles, followed by plasma membrane rupture and subsequent loss of intracellular contents 1 .
From a biochemical perspective, cellular energy decoupling is key to this process and develops very early in cell necrosis leading to point-of-noreturn events that are driven by sustained signals stemming primarily from the mitochondria, and which microscopically, finally become evident as perinuclear clustering of mitochondria associated with cytosolic membrane rupture 4 . This death-inducing process originates from an abrupt transitional change in the permeability state of the IMM and stems from the formation and expansive opening of the mPTP. Hence, uncontrolled opening of the mPTP, which spans the intermembrane space, is considered to be the molecular pathway responsible for the initiation and maintenance of the cytosolic efferent pathways of necrosis 5 . Consequently, therapies aimed at restoration of normal mitochondrial function, and in particular normal IMM permeability, have been identified as potential strategies for intervention and prevention of necrosis following ischaemiareperfusion. Of particular interest to anaesthetists, recent data suggests that volatile anaesthetic agents as well as propofol both interact with the mPTP during ischaemia-reperfusion and attenuate mitochondrial permeability transition, thus ameliorating the flow-on effects of necrotic cell death.
Interestingly, the mPTP does not exist natively within the mitochondrial membranes, but is believed to condense within the IMM in response to ischaemiareperfusion. Following Ca 2+ overload and oxidative stress, multiple channels, approximately 2 to 2.6 nm in diameter, accumulate as a result of conformational changes to pre-existing proteins located within the IMM and mitochondrial matrix, thus forming the mPTP. Uncontrolled opening leads to rapid bulkmovement of protons, water and solutes less than 1.5 kDa into the inner matrix of the mitochondria 6 . This influx of protons results in collapse of the mitochondrial inner membrane potential (Ψm), uncoupling of oxidative phosphorylation, and rapid depletion of adenosine triphosphate (ATP) stores. Meanwhile, simultaneous water and solute influx leads to mitochondrial swelling and rupture 7, 8 . Together, this causes irreparable mitochondrial injury and subsequent cell necrosis.
Pore activation is considered a two-step sequence that involves initially pre-swelling assembly followed by a Ca 2+ -driven positive-feedback autocatalytic propagation of Ca 2+ -cycling and ATP depletion that causes an expansive and sustained opening of the channel 9 . A number of factors can be shown to promote pore assembly within the IMM. These are an increase in matrix Ca 2+ levels 8 , oxidative stress 10 , collapse of ΔΨm 11 , and severe intra-mitochondrial matrix acidosis 12 . Although intra-mitochondrial acidosis (pH <7) can trigger the structural assembly of the pore, it is in fact paradoxically a potent inhibitor of mPTP opening 11, 13 . Indeed, experimental data from isolated mitochondria utilising tritiated markers of mPTP opening, suggest that the pore remains tightly closed during the cellular ischaemic event (most likely due to an inhibitory effect of the intra-mitochondrial protons that accompany the matrix acidosis). However, during reperfusion there is extensive pore opening as the acidosis is subsequently cleared 14, 15 . Furthermore, the rate and degree of subsequent mPTP opening during reoxygenation is proportionally related to the severity of the initial ischaemic insult 14 .
Besides matrix acidosis, the immunosuppressant cyclosporin A 16 , its non-immunosuppressive analogues, N-methyl-valine cyclosporin and N-methylisoleucine cyclosporin 17 , sanglifehrin A 18 , bongkrekic acid 19 , trifluoperazine 20 , magnesium, certain ubiquinone analogues 21 as well as volatile anaesthetic agents 22 and propofol 23 have all been shown to either block the open state or prevent assembly of the mPTP, thus preventing both necrotic and apoptotic cell death. This has been demonstrated in hepatocyte cell cultures 24 , working isolated hearts 14 and glutamateinduced neuronal excitotoxicity preparations 25 .
Apoptotic cell death
Apoptosis (programmed cell death type I) is an energy-dependent mechanism that results in cellular breakdown and elimination. It occurs either secondary to gene transcription-mediated responses that follow moderate cellular stress and injury, such as ischaemia-reperfusion, or in response to specific cellular cytokine-receptor interactions 26 . Its morphological characteristics include nuclear and cellular condensation with chromatic margination and preservation of organelles 1 . The process is followed by cellular fragmentation into membranebound apoptotic bodies, which undergo phagocytosis by surrounding cells. As there is no subsequent release of intracellular components, there is little or no associated inflammatory response 1 . A common method of identification and quantification of apoptotic cells in tissue sections is the TdT-mediated dUTP-biotin nick end-labelling assay, which detects oligonucleosomimic DNA fragmentation 27 . In pathological circumstances, specific mitochondrial signals activate cellular apoptotic processes causing programmed death of cells that would otherwise be regarded as necessary for routine tissue function. This has been observed in both cardiac and neuronal cells, and in particular, as a response to oxidative stress following ischaemia-reperfusion injury [28] [29] [30] [31] [32] . The key mediators of apoptotic cell death are cys-protease enzymes known as caspases. These mediate a controlled cascade of protein cleavage and activation that results in assembly of protein oligomers, which attack and disassemble the underlying cellular architecture.
Two inter-related pathways have been shown to induce apoptotic cell death. The extrinsic pathway is initiated by activation of cell-surface death-receptors and causes activation of cytosolic caspase-8. The molecular mechanisms are not related to ischaemiareperfusion injury, and therefore remain outside the scope of this review; however, summaries can be found elsewhere 3, [33] [34] [35] . In contrast, the intrinsic pathway originates from mitochondrial membrane permeability changes and causes the subsequent release of cytochrome c and caspase-3 activation. Furthermore, ischaemia-reperfusion injury initiates this process through modified mPTP activation 36 , leading to release of mitochondrial pro-apoptotic factors, such as cytochrome c, apoptosis-inducing factor, and second mitochondrial-derived activator of caspase (Smac/DIABLO) 37, 38 .
In order to initiate apoptosis, it is necessary for these triggering agents, which normally reside within the mitochondrial intermembrane space, to gain access to the cytosol. However, since their molecular size largely exceeds the outer mitochondrial membrane channels, a change in the mitochondrial outer membrane permeability is necessary.
In certain scenarios, for example, during mild to moderate ischaemic stress, decoupling of oxidative phosphorylation may occur in an incomplete fashion, preventing full depletion of ATP stores. Consequently, mPTP channels that had opened as the result of an ischaemia-reperfusion insult may actually re-close during late reperfusion. Closure prevents complete ΔΨm depolarisation, thus allowing oxidative phosphorylation to re-initiate. However, such transient mPTP opening still leads to solute and water influx into the mitochondria causing swelling of the mitochondrial matrix. The infoldings of the IMM usually can accommodate acute increases in matrix volume. However, the outer membrane, which lacks the same cristal folds, is less likely to. This differential swelling is believed to cause rupture of the outer mitochondrial membrane and release of pro-apoptotic initiator proteins such as cytochrome c from the inter-membrane space 39, 40 (Figure 1 ).
As to whether apoptosis contributes clinically to loss of cellular tissue in ischaemic injury has been debated; however, ischaemia-reperfusion is reported to have components of both necrosis and apoptosis combined [41] [42] [43] [44] [45] . Indeed, there is laboratory and clinical Electrons removed from flavin adenine dinucleotide hydroquinone (FADH 2 ) are added to the ubiquinone pool by complex II. Normally 1 to 4% of electron transfer involved in respiration is incomplete and leaks from the transport system in the form of superoxide. Complex III transfers electrons via cytochrome c, normally bound to cardiolipin, to complex IV where molecular oxygen accepts the electrons and is reduced to water. The free energy liberated from this series of redox reactions is used to move protons into the intermembrane space thus producing a proton gradient which is subsequently utilised by complex V to drive F 1 -F 0 -ATPase enzyme in the reverse direction resulting in oxidative phosphorylation. data suggesting that during reperfusion injury, apoptosis can occur at the same time as cellular necrosis, especially at the border zones of ischaemic tissue where the ischaemic insult may be less severe. In these areas mitochondrial signals normally responsible for necrosis may switch, depending upon the redox state of the cell, and subsequently contribute to apoptotic-mediated cell death 46 . This has been demonstrated in both animals and humans, in which apoptotic injury has been identified in the border zone of infarcted tissue following myocardial infarction 47, 48 .
Triggers of pore assembly ATP depletion
ATP is produced within the mitochondrial matrix and its transport to extra-mitochondrial sites occurs via a six-helix bundle inner mitochondrial membrane transport protein known as the adenine nucleotide translocase (ANT) 49 . The ANT plays a specific role in mPTP regulation and any manoeuvre that decreases adenine nucleotide binding to the ANT, for example overall mitochondrial de-energisation during ischaemia, can trigger pore assembly 50 . Experimentally, mPTP opening can be induced by adenine nucleotide depletion and reversed by addition of ATP or adenosine diphosphate (ADP) 51 . The electron transfer system in its resting state is responsible for a very small source of electron leak from complexes I and III which causes a background level of superoxide-producing events known as reactive oxygen species (ROS) "flashes" 52 ( Figure 2 ). During ischaemia, there is injury to the enzymes involved in mitochondrial respiration, in particular to enzyme complexes III and IV located within the distal electron transport system. Lack of molecular oxygen specifically inactivates the cardiolipin-cytochrome c electron shuttle between these two enzyme complexes and causes a loss of electron transport power in the respiratory chain [53] [54] [55] . In addition, there is also an increase in IMM leakiness, in which protons can move back into the mitochondrial matrix without passing through the complex V protein. Consequently, this leads to a proton-motive force within the intermembrane space that still permits electron transport along the electron transport system, but due to exclusion of proton transport through complex V, prevents ATP generation. Indeed it is possible to induce this experimentally in isolated mitochondria, and is known as state 4 mitochondrial respiration 56 . In the presence of ongoing ischaemia, the loss of the normally high proton gradient across the IMM and a reduction in the reduced levels of adenine nucleotides causes the F 1 F 0 -ATPase enzyme of complex V of the electron transport system to hydrolyse ATP to ADP. The energy stored in the chemical bonds of ATP is subsequently converted to mechanical rotational energy and dissipated within the rotary subunits of this enzyme complex 57 . Hydrolysis of ATP therefore leads to a net loss in energy-rich phosphorylated adenine nucleotides. As ADP is degraded into its individual components, there is an increase in nucleoside bases and tissue phosphate concentration within the matrix 58, 59 . This subsequent increase in inorganic phosphate has been shown to co-activate the mPTP in the presence of Ca 2+ 60 . Hence ATP depletion, not only prevents inhibition of mPTP opening, but also directly activates mPTP assembly.
Matrix calcium overload
The accumulation of intra-mitochondrial Ca 2+ is critical in determining cell fate. During ischaemia, oxidative stress results in a sustained slow increase in cytosolic Ca 2+ , which upon reaching an intracellular concentration of 1 to 3 µM causes an abrupt increase in intra-mitochondrial Ca 2+ 61,62 . Ischaemic intra-mitochondrial Ca 2+ overload, accompanied by significant depletion of adenine nucleotides and tissue phosphate accumulation, together co-operate to enhance sensitivity to uncontrolled mPTP assembly and opening [63] [64] [65] . Indeed, high concentrations of Ca 2+ have been shown to overcome mPTP inhibitors such as cyclosporin A 14, 19, 66 .
During ischaemia, the exact sequence of Ca 2+ overload in mitochondria appears to begin late in the ischaemic phase and then continues into reperfusion with the level of intra-mitochondrial Ca 2+ present at the conclusion of ischaemia best correlating with the subsequent degree of cell death that is seen to occur later during reperfusion 66 . However, it is now clear that Ca 2+ -induced mPTP opening, and the consequences thereof, appear to vary, dependent upon the circumstances involved in pore assembly. For instance, when mitochondrial permeability transition is induced in rat hepatocytes with the oxidant chemical tert-butylhydroperoxide, the increase in mitochondrial Ca 2+ is seen to clearly precede the onset of changes in inner membrane permeability.
Furthermore, subsequent Ca 2+ chelation reduces the generation of mitochondrial ROS, the onset of permeability transition and subsequent cell death 67 . This can also be seen in the cytotoxicity induced in Reye's syndrome and storageinduced reperfusion injury to the liver, in which Ca 2+ overload is obligatory in inducing mPTP opening 68, 69 . However in contrast, there is conflicting data in cardiomyocytes that suggests ischaemia-reperfusion injury and consequent Ca 2+ overload is initiated as a result of bioenergetic failure following oxidative stress, and occurs as a consequence of, rather than as a primary source of, pore opening 10 . This discrepancy in the causal factors that trigger pore assembly may be explained by the observation that cardiomyocytes, as opposed to hepatocytes, normally experience constant fluctuations in free Ca 2+ levels associated with excitation-contraction coupling. Therefore, cardiac tissue may indeed show greater resistance to Ca 2+ -induced permeability transition, but significant sensitivity to mPTP opening as a result of induced oxidative stress. It is important to note, however, that Ca 2+ overload has a pronounced effect upon mPTP opening when accompanied by ATP depletion, for it is indeed possible to prevent cell necrosis, despite high intra-mitochondrial Ca 2+ levels, if an alternative source of ATP is supplied to re-establish ΔΨm. This has been demonstrated experimentally by reperfusion of ischaemic hepatocytes with the glycolytic substrate fructose or the cytoprotective amino acid glycine 70 .
FiGure 3: Molecular pathway of mitochondrial ischaemia and model of permeability transition pore activation. Mitochondria sustain progressive damage during ischaemia. An initial deficit to complex I occurs early during ischaemia with damage to the nicotinamide adenine dinucleotide hydride (NADH) dehydrogenase component resulting in increased electron leak. At the same time ischaemic damage to complex V results in a loss of adenosine triphosphate (ATP) production. Sustained ischaemia causes functional injury to the iron-sulfate protein subunit of complex III, leading to a subsequent increase in the electron leak. The electrons, channelled away from normal respiration, are transferred directly to residual oxygen resulting in superoxide production. Cardiolipin peroxidation by reactive oxygen species (ROS) delocalises cytochrome c from its normal binding sites on the inner mitochondrial membrane, while selective depletion of cardiolipin also causes injury to complex IV, further impairing cellular respiration. Functional inactivation of complexes I, III and IV prevents normal proton transfer into the intermembrane space resulting in an increase in matrix proton concentration (low pH). At the same time an increase in cellular Ca 2+ concentration is mirrored by an increase in the mitochondrial matrix Ca 2+ content. A). One model of pore formation involves low ATP, high Ca 2+ and ROS as potent triggers for mitochondrial permeability transition pore (mPTP) assembly caused by translocation of Ca 2+bound cyclophilin D to the inner membrane with functional association of the adenine nucleotide transferase and phosphate carrier proteins to form the mega-channel. B). The channel remains closed during ischaemia due to the low matrix pH. Injury to the electron transfer system occurs in a heterogeneous fashion such that during reperfusion, re-energisation of damaged electron transfer subunits further aggravates electron leak resulting in continued superoxide generation. C). However, with re-oxygenation, cellular respiration may in fact resume in various undamaged subunits resulting in partial clearance of protons from within the matrix. Restoration towards a normal pH within the mitochondrial matrix removes the inhibition upon mPTP opening leading to widespread pore opening, influx of solutes and water, collapse of the inner membrane potential, ATP hydrolysis and swelling or rupture of individual mitochondria. ANT=adeninine nucleotide transferase protein, PiC=phosphate carrier protein, CyPD=cyclophilin D, O 2 .-=superoxide, e -=electron, Pi=phosphate, H + =proton, NAD=nicotinamide adenine dinucleotide, UQ=ubiquinones, FADH 2 = flavin adenine dinucleotide hydroquinone, FAD=flavin adenine dinucleotide, CL-perox=peroxidated cardiolipin, Cyt C=cytochrome c.
Reactive oxygen species
There is a large body of in vitro and in vivo evidence that implicates matrix Ca 2+ overload alone as a potent trigger of mPTP opening 8, 12, 19, [71] [72] [73] . However, there are also data indicating that high-level ROS bursts in certain circumstances have a primary effect on mPTP opening, and may in fact abrogate the need for excessive intra-mitochondrial Ca 2+ build up as the primary event causing mPTP assembly 10, 74, 75 .
Normal oxidative signalling that occurs in healthy cells is markedly impaired during ischaemia 76 . Oxidative damage and cytotoxic ROS produced at complex III, leads to a decrease in cardiolipin content in the IMM 54 . Upon reperfusion, there is a re-energisation of the electron transfer system that causes an electron leak and a burst of ROS formation with clearance of protons from within the mitochondrial matrix 52 . Multiple sources are implicated in the subcellular and molecular origins of mitochondrial ROS generation. However, prime amongst these is the rebound of normal superoxide flash activity that was previously impaired during the ischaemic period. This leads to direct transfer of electrons to molecular oxygen predominantly occurring at complex III 77 (Figure 3 ). In addition, xanthine oxidase, acting on xanthine formed from the degradation of adenosine, as well as the activity of specific enzymes such as NADPH oxidase, nitric oxide synthase and various other lipoxygenases, all play a role in cytotoxic ROS generation 78, 79 . In each case, mitochondrial permeability transition caused by triggering ROS may coincide with bursts of further mitochondrial ROS generation 80 . This is known as ROS-induced ROS release and has been seen to occur among long chains of adjacent mitochondria, verifying apparent co-operativity between mitochondrial sub-populations 81 .
Structure of the mitochondrial permeability transition pore
The mPTP as a functional channel has not been cloned, nor has a specific gene responsible for its sole transcription been identified. However, there is significant evidence implicating the ANT, as an integral component of the protein aggregates that comprise the mPTP. It is the most abundant protein in the IMM and can undergo striking changes to its molecular composition during periods of induced oxidative stress 82, 83 . Moreover, specific substrates and antagonists for the ANT, such as carboxyatractyloside and bongkrekic acid respectively, have similar effects on mPTP function 49, 84, 85 . In addition, a high ATP level which is known to promote the 'm' or matrix-facing conformation of the ANT, prevents mPTP opening, while supra-normal intra-mitochondrial Ca 2+ levels, which interact with the ANT in its 'c' or cytosolicfacing conformation, favour mPTP opening 19 .
Initial theories of the mPTP assembly suggested an interaction of the ANT with a mitochondrialmatrix peptidyl-prolyl cis-trans isomerase (PPIase) enzyme that has subsequently been identified as cyclophylin-D 19 . This is a member of a superclass of proteins known as immunophillins, which have PPIase activity. Although their transcription level and function currently remain unknown, they show marked conservation of structure across many different phyla 86 . During induced oxidative stress, matrix-bound cyclophylin-D translocates to the IMM and coincides with mPTP assembly 12 . Moreover, it has been demonstrated that cyclophylin-D contains the binding site for the cyclosporin A inhibition of mPTP opening 16, 87 . Cyclophylin-D-deficient mice show significant resistance to cyclosporin A sensitive permeability transition and this finding is an important clue to the structure of the pore 88 . Taken together, there is strong circumstantial evidence indicating that the ANT and cyclophylin-D are fundamental components or at least regulators of mPTP function.
One model proposed for mPTP structure and assembly involves the ANT as a regulatory protein and places the phosphate carrier protein as the central protein responsible for the pore-forming component of the channel 85, 89, 90 . Pore formation therefore involves a calcium-triggered, cyclophylin-D-facilitated structural change of the phosphate carrier protein, which is modulated by the conformational state of a closely associated ANT protein molecule ( Figure 3 ).
However, there are experimental data not explained by this theory. First, ANT1/ANT2 knockout mice have been shown to undergo cyclosporinsensitive permeability transition at much higher matrix concentrations of Ca 2+ 91 . Second, although mPTP opening appears to be Ca 2+ sensitive and cyclosporin A reversible, there also exists a highlevel induction state of unregulated opening, which is insensitive to cyclosporin A, and appears more consistent with the ROS-induced opening and does not require Ca 2+ as a triggering factor 10, 74, 75 . Recent work has shed light on other possible explanations for mPTP structure. It has been suggested that ATP depletion and oxidant stress may cause misfolding and aggregation of integral membrane proteins, such as the ANT, to condense within the IMM and form the mPTP. Normally the matrix protein cyclophylin-D is capable of acting as a chaperone-like molecule and blocks conductance through these misshapen protein aggregates. Cyclophylin D has foldase activity, which may have a physiological role of promoting repair of the misfolded protein channels back towards a thermodynamically stable state. The initial conductance blockade that results from cyclophylin-D binding to misfolded mPTP pores can be reversed by Ca 2+ binding to cyclophylin-D-bound protein complexes, and thus Ca 2+ -induced sensitivity in itself can be antagonised by cyclosporin A through competition for Ca 2+ binding sites on cyclophylin-D. However, when misfolded protein aggregates greatly outnumber cyclophylin-D chaperone molecules, pore opening occurs in a Ca 2+ -insensitive fashion, which cannot be reversed by cyclosporin A 92 . Other proteins besides the ANT may also misfold and contribute to mPTP formation explaining why it is possible to demonstrate permeability transition in ANT1/ANT2 knockout mice 91 (Figure 4 ).
ROLE OF THE MITOCHONDRIAL PERMEABILITY TRANSITION PORE IN VOLATILE MEDIATED PRE-AND POST-CONDITIONING
Brief exposure to volatile anaesthetic agents before or after index ischaemia have been found to induce a myocardial phenotype that is protective against ischaemia-reperfusion mediated cell death, for which the processes have been termed anaesthetic preand post-conditioning respectively. Furthermore, similar to anaesthetic pre-and post-conditioning, short periods of induced ischaemia before and after a longer ischaemic event have also been found to induce cellular protection. It is interesting to note that irrespective of whether the trigger that induces protection is periodic ischaemia or a volatile FiGure 4 : Molecular pathway of mitochondrial ischaemia and alternative model of permeability transition pore activation. Ischaemic damage to the respiratory chain of enzymes occurs in the same fashion as described in Figure 2 . A). An alternative model of pore formation involves adenosine triphosphate (ATP) depletion and an associated ischaemic burst of superoxide from complexes I and III which together cause misfolding and aggregation of integral membrane proteins, such as the adenine nucleotide transferase and phosphate carrier proteins to condense within the inner membrane and form the mitochondrial permeability transition pore. Normally the matrix protein cyclophylin-D is capable of acting as a chaperone-like molecule and blocks conductance through these mis-shaped protein aggregates thus promoting repair of the misfolded protein channels back towards a thermodynamically stable state. B). The initial conductance blockade that results from cyclophylin-D binding to misfolded mitochondrial permeability transition pore (mPTP) pores can be reversed by high intramitochondrial [Ca 2+ ] by binding of Ca 2+ to cyclophylin-D-bound protein complexes. C). Ca 2+ -induced sensitivity in itself can be antagonised by cyclosporin A through competition for Ca 2+ binding sites on cyclophylin-D, thus blocking conductance through the pore. D). When misfolded protein aggregates greatly outnumber cyclophylin-D chaperone molecules, pore opening occurs in a Ca 2+ -insensitive fashion, which in addition, cannot be reversed by cyclosporin A. anaesthetic, a striking number of similarities have been demonstrated to exist between both molecular mechanisms. Recent data points towards the mPTP as being a downstream effector pathway by which both anaesthetic and ischaemic pre-and post-conditioning mechanisms have been shown to converge upon 22, [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] . Indeed, the mPTP is considered the ultimate effector pathway, through which inhibition by anaesthetic agents is not only considered to significantly contribute to the prevention of necrotic and apoptotic cell death, but is now considered the terminating pathway for processes which had previously been attributed to pre-and postconditioning mediated cellular protection. Although the mechanistic pathways for anaesthetic pre-and post-conditioning still remain to be fully delineated, evolving experimental data suggests that both processes significantly inhibit opening of the mPTP.
Volatiles administered before ischaemia-reperfusion prevent mPTP opening
Anaesthetised rabbits, preconditioned with 30 minutes of 1 minimum alveolar concentration of desflurane (8.9%) followed by a 15 minute washout, when exposed to temporary coronary artery ligation, exhibit reduced Ca 2+ -induced opening of the mPTP in mitochondria that are subsequently isolated from the hearts of these animals 105 . Furthermore, when 5-hydroxydecanoate (5-HD), a specific antagonist to the mitochondrial potassium ATP (mitoKTP) channel, was pre-administered it abolished the effects of desflurane on mPTP opening, indicating that mitoKTP channel activation is upstream of the effects on mPTP function 105 .
Pre-conditioning with isoflurane prevents the ROS-induced mPTP opening that follows laserillumination of isolated rat cardiomyocytes when loaded with the fluorescent probe tetramethylrhodamine ethylester 22 . In a similar fashion, isoflurane-mediated mPTP closure was abolished when rats were pre-exposed to the non-selective protein kinase C (PKC) inhibitor chelerythrine and the selective PKC ε-isoform inhibitor εV1-2, but not when pre-exposed to the selective PKC δ-isoform inhibitor, rottlerin 22 . This indicates that PKC-ε activation by volatiles is also an upstream process and necessary for volatile-mediated mPTP closure. Furthermore, isolated mitochondria directly exposed to isoflurane in the absence of any cytosolic machinery exhibited no inhibition of mPTP opening.
Mechanism
The exact initiating event by which volatiles prevent mPTP opening is unknown, but evidence points to a specific effect of volatile anaesthetic agents on attenuating electron transport within the chain of respiratory proteins located within the inner mitochondrial membrane. Under hypoxic conditions, ischaemic injury causes damage to complex III of the electron transport chain, which results in cytotoxic ROS generation during ischaemia-reperfusion 52 and oxidative triggering of pore assembly 81 . Consequently, during ischaemia, it is possible to induce a protective stage against further mitochondrial injury by inhibiting electron transport through the electron transfer chain of enzymes. Indeed, permanent prevention of electron flow into complex III, by rotenonemediated upstream blockade of complex I, has been shown to attenuate cytotoxic ROS production upon reperfusion 106 . Furthermore, reversible blockade of electron transport during ischaemia at complex I by amobarbital results in partial uncoupling of mitochondrial respiration thus allowing re-initiation of oxidative phosphorylation and prevention of cardiac injury during reperfusion 55 . Similarly, volatile pre-conditioning causes an increase in reduced nicotine adenine dinucleotide 107 , and data from isolated mitochondria in state 3 respiration indicates that volatiles also attenuate mitochondrial electron transport and inhibit electron flow into the transport chain 108 . However, although the mechanism by which volatiles inhibit electron transport is unclear, recent data has shown that sevoflurane impairs mitochondrial respiration by a ROS and nitric oxide dependent mechanism 108 . Thus volatiles may initially directly inhibit complex III activity, and cause superoxide and nitric oxide induced feedback impairment of complex I 108, 109 . Indeed, superoxide generated from the electron transport chain by other experimental means has been shown to concurrently attenuate mitochondrial electron transport 110 . For example, the net result of both sevoflurane 111 or isoflurane 102 preconditioning is simultaneous superoxide generation from the electron transfer chain in minute quantities, which results in attenuation of electron transport. Indeed blockade of this volatile-induced ROS-signalling by ROS scavengers causes a much greater damaging release of cytotoxic ROS later during reperfusion 111 . Moreover, ROS-signalling observed during sevoflurane exposure is not affected by any of the PKC 112 or mitoKTP inhibitors 108 indicating ROS-signalling and attenuation of electron transfer precede PKC and mitoKTP activation. It has been suggested that the zinc finger motifs present in PKC-ε allow for modification of structure and function by superoxide following ROS-signalling by volatile anaesthetics. Interestingly, mitochondrial ROS generators such as menadione 113 and antimycin A 114 have also been shown to initiate cardioprotection in a fashion similar to that seen with volatile agents.
The minor reduction in ΔΨm caused by the influx of K + associated with activation of the mitoKTP channel, which follows PKC-ε translocation 115 , is believed to affect mPTP formation. This has been demonstrated with pharmacological agents that are known to directly open mitoKTP channels, and which also prevent mPTP opening 116 , and is reinforced by the observation that partial mitochondrial depolarisation is associated with cell survival. This has been demonstrated by the protonophore electron uncouplers 2,4-dinitrophenol 117 and FCCP 118 , as well as with isoflurane 102 . Although these agents cause partial mitochondrial depolarisation by different mechanisms, both protect cardiomyocytes from oxidative stress by preventing cytotoxic ROS formation and delay mPTP opening 102, 117 . This suggests that a partial decrease in ΔΨm, seen with volatile mediated mitoKTP opening, underlies the delay in mPTP opening and subsequent improvement in cell survival.
Taken together there is sufficient circumstantial evidence to indicate that volatile anaesthetic agents initiate a protective pathway converging upon the mPTP that initially involves attenuation of electron transfer with associated superoxide signalling from the electron transport chain 108, 109, 111 . It has been proposed that this in part causes PKC-ε phosphorylation and translocation 112, 114, [119] [120] [121] FiGure 5 : Proposed molecular pathways of volatile anaesthesia mediated pre-and post-conditioned triggered prevention of mitochondrial permeability transition pore assembly. A). Volatile anaesthetic agents attenuate complex III activity in a non-ischaemic fashion and leads to an increase in electron leak in the form of superoxide. Superoxide may react with nitric oxide to form peroxynitrite, which attenuates electron transport at complex I resulting in further superoxide generation. In such scenarios, the amount of superoxide generated is much less than that seen during progressive ischaemia. Consequently superoxide acts as a second messenger and promotes the translocation of epsilon subunit of protein kinase C (PKC-ε) to the inner mitochondrial membrane. Phosphorylation of PKC-ε causes opening of mitochondrial K-adenosine triphosphate channels, causing an influx of K + into the mitochondrial matrix and slight depolarisation of the inner membrane potential (Ψm). Such reductions in Ψm have been shown experimentally to prevent pore assembly. B). Volatile anaesthetic agents have been shown to inhibit mitochondrial permeability transition pore (mPTP) opening during reperfusion through reactive oxygen species mediated activation of the RISK pathway, which incorporates dual activation of maintenance of matrix volume and membrane integrity. This consequently prevents the cascade of cytotoxic ROS formation, Ca 2+ accumulation, mPTP assembly with uncontrolled opening, and associated ATP depletion ( Figure 5 ).
Volatiles administered following ischaemia prevent mPTP opening
Administration of volatile anaesthetic agents early in the reperfusion period can also attenuate mPTP opening. For example, similar to the effects seen with pre-conditioning, administration of isoflurane following ischaemia inhibits mitochondrial respiration, depolarises mitochondria and prevents mPTP opening 100 . Isolated perfused rat hearts exposed to 3% sevoflurane during the first 15 minutes of reperfusion demonstrate improved functional recovery and decreased infarct size secondary to inhibition of mPTP opening 127 . This effect is reversed with the co-administration of drugs that directly open the mPTP such as atractyloside 97 , and by the ROS scavenger N-acetylcysteine 104 , and suggests that sevoflurane-mediated post-conditioning cardioprotection also results in inhibition of postischaemic oxidative-triggered mPTP opening.
Mechanism
In a similar fashion to pre-conditioning, it is possible to induce post-conditioning by either ischaemic or pharmacological means. Signal-transduction in post-conditioning involves at least two parallel pathways that also converge upon mPTP function ( Figure 5 ). Mechanistic details of these two pathways, known as the reperfusion injury salvage kinase (RISK) pathway and the survivor activating factor enhancement (SAFE) pathway are beyond the scope of this review; however, excellent summaries can be found elsewhere 128, 129 . Briefly, inhibition of mPTP opening at reperfusion by distal interacting components of the RISK cascade involve dual activation of phosphoinositide 3-kinase (PI3-K), protein kinase-B/AKT, and endothelial nitric oxide synthase (eNOS) 130 as well as activation of mitogenactivated protein kinase (MAPK), extracellular signal-regulated kinase (ERK 1/2), and P70S6K mediated inhibition of glycogen synthase kinase 3beta (GSK3β) 131, 132 . The SAFE pathway also plays a role in post-conditioning, especially the delayed second window of protection, and involves participation of TNF-α and kinase JAK-mediated phosphorylation of STAT3 133 . STAT3 is known to translocate to the nucleus and results in changes in gene transcription of anti-apoptotic proteins, such as Bcl-2 134 , as well as inhibition of pro-apoptotic factors, such as Bax 132, 135 , resulting in delayed protection. Indeed significant interactions between Bcl-2 and the mPTP have been described, and delayed ischaemic preconditioning is associated with enhanced Bcl-2 expression, mPTP inhibition, reduced mitochondrial swelling, and subsequent cardioprotection 101 . It has also been suggested that STAT3 is necessary for immediate post-conditioning protection by localising to the mitochondria and affecting mPTP closure 136 involving possible cross-talk with GSK3β inhibition 137 .
Extensive data suggest that volatile anaesthetic agents act as post-conditioning triggers affecting mPTP closure via RISK pathway activation. For instance, sevoflurane closes the mPTP via upstream activation of Akt and ERK 1/2 signalling pathways 104, 138 . Desflurane post-conditioning protects the human myocardium through the RISK activation of P70S6K and eNOS, and leads to GSK3β-mediated closure of the mPTP 99 . Isoflurane administered at the onset of reperfusion improves functional recovery and decreases infarct size in Langendorff perfused rat hearts by PI3-K mediated Akt and GSK3β upstream effects upon mPTP function 95 . In an in vivo rabbit preparation, the same effects were demonstrated by isoflurane with activation of ERK 1/2, P70S6K, and eNOS 139 . Similarly, isoflurane post-conditioning exposure protects mouse hearts from reperfusion injury by preventing mPTP opening via an eNOSdependent mechanism 140 . These effects can be attenuated by the co-administration of atractyloside 141 , thus underpinning the interplay that volatiles have on all the intermediary components of the RISK pathway with ultimate prevention of permeability transition and the associated marked mitochondrial depolarisation that occurs with uncontrolled opening of the mPTP 142 .
As described above, the link between postconditioning volatile-induced RISK pathway activation and the relationship to the mPTP has been well established. However, there is less documented evidence making a case for the association of postischaemic SAFE pathway activation with volatiles and closure of the mPTP. Although SAFE pathway activation has been demonstrated to result in transcriptional changes in pro-and anti-apoptotic members of the Bcl-2 family of proteins, and although there is evidence that volatiles cause an increase in the activity of anti-apoptotic Bcl-2 143 , and reduction in pro-apoptotic activity of Bax 132, 135 , there is only limited work suggesting a causal link with possible SAFE pathway mediated mPTP closure and volatile administration during the reperfusion period. For example, the selective Bcl-2 protein inhibitor HA14-1 impairs the post-conditioning cardio-protective effects of isoflurane. This effect can be reversed with the co-administration of cyclosporin A, and implies a link between volatile post-conditioning, Bcl-2 and the mPTP 144 . As to whether this is mediated by SAFE or RISK pathway processes or cross-talk between the two, has not been determined. However, speculation that these pathways may indeed interact with the mPTP in series or parallel via mitoKTP activation has been suggested by experimental data in which sevoflurane, administered during reperfusion, was seen to inhibit mPTP opening and consequently prevented apoptotic cell death 127 .
Taken together, this data indicates that postischaemic administration of volatiles produces cellular protection by inhibiting mPTP opening during reperfusion through multiple pathways, of which, the mechanisms include a) ROS-mediated activation of the RISK pathway 95, 99, 104, [138] [139] [140] [141] [142] , b) indirect modulation of the anti-apoptotic Bcl-2 protein possibly through SAFE pathway interaction 132, 143, 144 and c) regulation of mitoKATP channel opening 127 .
ROLE OF THE MITOCHONDRIAL PERMEABILITY TRANSITION PORE AND CARDIOPROTECTION WITH PROPOFOL
Propofol is a potent scavenger of ROS. In vitro experimentation has identified propofol as possessing an action on the mPTP following ischaemia-reperfusion, in part due to its property as a ROS scavenger. Isolated rat hearts perfused with propofol in a crystalloid buffer solution before and after ischaemia at a concentration of 2 mg/l, demonstrated a significant improvement in post-ischaemic left ventricular dysfunction and were associated with reduced mPTP opening as determined by mitochondrial tritiated deoxyglucose entrapment 23 . Other researchers have also demonstrated similar inhibitory properties of propofol upon the mPTP. However, these effects were only evident at concentrations much higher than those delivered in clinical anaesthetic practice 145, 146 . Propofol administered in high concentrations is known to produce a wide range of non-specific effects including increased fluidity of biological membranes, which has consequent effects upon ion channel function, and conceptually it may therefore have additional effects upon the mPTP other than simple attenuation of opening due to its property as a ROS scavenger 147, 148 . Interestingly, when propofol is added directly to isolated de-energised mitochondria at a concentration of 2 mg/l, as opposed to delivery via perfusate through the coronary arteries in isolated hearts, no effect upon mPTP opening is seen 23 . In contrast, significant inhibition of mitochondrial swelling has been demonstrated by direct application of propofol at a higher concentration of 100 µM (19.6 mg/l) 149 . This indicates that at lower doses the protection seen with propofol requires either an intact mitochondrial-cytosolic continuum or mitochondria that are undergoing phosphorylating conditions, and that when administered at higher concentrations propofol may have a direct effect upon mPTP closure alone. At increasing concentrations propofol will also prevent the oxygen free radical mediated peroxidation of cardiolipin 150 . Damage to cardiolipin has been recognised as the first step in the mobilisation of cytochrome c and a concurrent initiating step in oxidative-induced mPTP associated apoptotic cell death (Figures 3  and 4 ). This property of propofol can be detected at approximately 9 mg/l, but similarly to its effects on the mPTP, is also dose-dependent, as it is even greater at 18 mg/l 150 . Together, this may explain why high dose propofol when administered during global myocardial ischaemia in vitro, results in attenuation of the mechanical, biochemical, and histological changes caused by ischaemia-reperfusion 151 .
However, unlike with volatile anaesthesia, to extrapolate the protective effects of propofol from concentrations delivered in animal work to clinical practice may not be straightforward. In humans, protein binding of propofol in whole blood is significant and the free levels seen clinically at high total blood concentrations are only a fraction of those that are required to scavenge ROS and inhibit mPTP opening in vitro 152 . Although the total whole blood concentration of propofol (free and bound) can be significant, propofol has a high octanolbuffer partition coefficient, and only the free drug is considered to cross biological membranes. Consequently a free propofol concentration greater than 0.5 µM (0.098 mg/l) in the immediate intracellular environment, such as mitochondria, is often considered unlikely at the clinical concentrations of propofol that are delivered in whole blood 153 . In laboratory studies, propofol is either delivered in a crystalloid buffer-perfusate to isolated perfused hearts or applied directly to isolated mitochondria, thus negating the significant limitations on the free level, which are known to occur with protein binding in clinical studies. This is an important issue, because the ROS-scavenging effects of propofol and its effects upon mPTP function have been described with most in vitro preparations at concentrations ranging from 2 to 18 mg/l 23, [149] [150] [151] . Such concentrations are up to nine times the whole blood concentrations observed in patients clinically and therefore can be as high as 200 times the free drug concentration that may occur at the level of the mitochondria in vivo 153 . This suggests that the free levels of propofol present during anaesthesia may be, comparatively, so low that there is significant limitation in free radical scavenging and mPTP inhibition. This effect, mainly evident at higher concentrations of propofol 154 , may explain the clinical data that points towards a superior protective effect seen with volatile anaesthesia when compared directly with that of propofol [155] [156] [157] [158] . However despite this hypothesis, and clinical data indicating the superiority of volatiles when compared to propofol, there is a small amount of limited clinical data that demonstrates that the cardioprotective effects of propofol are evident with infusion rates of 120 µg/kg/ minute 159 and 5 mg/kg/hour 160, 161 . These infusion rates appear high however, when protein binding is taken into account, it implies that the cardioprotective effects of propofol may be evident at the lower associated free levels and that protection may stem from more than its ability to scavenge free radicals.
CLINICAL STUDIES
There is a vast amount of experimental data indicating the protective effects of both volatile and intravenous agents in animals involving the mPTP. However, little work involving anaesthetic agents and the mPTP has been performed in humans 99 . As outlined above, the pre-and post-conditioning pathways of volatiles as well as the protective effects of propofol are both considered to converge upon the mPTP. To date the evidence suggests that mPTP inhibition by anaesthetic agents is indeed a cross species effect that also involves humans; therefore clinical studies that demonstrate a protective effect of anaesthetic-induced cell survival would conceptually have resulted in mPTP inhibition within the process of producing such observed effects.
Most human studies investigating anaestheticinduced organ protection have compared the use of volatile anaesthesia to propofol during cardiac surgery and have not specifically looked at the effects of anaesthetic agents upon mPTP function 121, [155] [156] [157] [158] . These studies have involved small numbers mostly powered for endpoints such as biochemical markers of myocardial ischaemia. Additionally, there have been a small number of human studies investigating the effects of volatiles upon brain [204] [205] [206] [207] [208] , renal 121,209-211 , hepatic 209, 210, 212 and endothelial 213 function. There is increasing evidence in humans supporting the antiischaemic properties of volatile agents, however only limited data in which improvement in clinical outcome has been reported 171, 207, 208, 214 . There is even less work investigating protection by propofol [159] [160] [161] 176, 203 . Furthermore, there is emerging clinical evidence suggesting that co-administration of propofol may impair the protection induced by volatiles 123, 195 . In contrast, it has been suggested that co-administration of isoflurane pre-ischaemia, with propofol held off until later during reperfusion, offers synergistic protection compared to either agent alone and is consistent with the mechanisms by which both agents lead to cell survival as outlined above 203 . Table 1 lists the analyses and clinical studies performed to date, investigating organ protection from the point of view of both volatile and intravenous anaesthetic agents.
A retrospective review of registry data from 10,535 surgical procedures comparing the influence of sevoflurane and propofol anaesthesia and looking at clinical outcomes, concluded that propofol anaesthesia might offer superior cardiac protection when administered to patients with severe ischaemia, cardiovascular instability, or in acute and urgent surgery 175 . A longitudinal study of 34,310 coronary artery bypass graft (CABG) interventions, performed between 2002 and 2004 in 64 Italian cardiac surgical centres correlated a risk-adjusted mortality ratio with volatile anaesthetic use in each cardiac centre. They demonstrated a reduced 30 day risk-adjusted mortality when volatile agents were used during cardiac surgery and that risk-adjusted mortality was lowest in those centres in which volatile anaesthetics were used for the majority of their cardiac surgical interventions and highest in those in which intravenous anaesthetics were predominantly used 215 .
In an attempt to assess whether anaesthetic agents affect outcome following ischaemia-reperfusion injury, a number of meta-analyses of pooled data have been published with conflicting results. An analysis of pooled data by Yu et al looked at 32 studies involving 2841 patients and revealed that although sevoflurane and desflurane reduced the postoperative rise in cardiac Troponin I, it did not translate into improved long-term outcome 216 . A meta-analysis by Symons et al identified 27 trials that included 2979 patients and showed no significant difference in myocardial ischaemia, myocardial infarction, intensive care unit lengthof-stay or hospital mortality between the groups. This study did identify that patients randomised to receive volatile anaesthetics had 20% higher cardiac indices, significantly lower cardiac Troponin I serum concentrations and lesser requirement for inotropic support compared with those randomised to receive intravenous anaesthesia 217 . 
Published data comparing intravenous and volatile anaesthetic agents on organ protection (continued)
A subsequent analysis by Landoni et al identified 22 studies involving 1922 patients. In this analysis, clinical investigations utilising the older volatile agents were excluded and only studies using sevoflurane and desflurane were included in the volatile arm in comparison to intravenous agents. Interestingly, it revealed significant reductions in both myocardial infarction and 30-day mortality in the volatile group 214 . The most recent meta-analysis compared sevoflurane to propofol in patients undergoing coronary artery surgery. The investigators identified 13 studies including 696 patients. The results showed that patients receiving sevoflurane had higher post-bypass cardiac index, lower cardiac Troponin I and myocardial ischaemia and shorter ICU and hospital lengths of stay. However there was no difference in mortality, myocardial infarction or atrial fibrillation between groups 218 .
CONCLUSION
Anaesthetic-induced organ protection has attracted much attention as a possible technique to reduce adverse cardiovascular outcomes. Cell viability after ischaemia is dependent upon morphological and functional changes that occur in the inner and outer mitochondrial membranes. Specifically, ischaemia results in damage to the electron transport chain of enzymes, and sets into play the assembly of a nonspecific mega-channel that transgresses the inner mitochondrial membrane, which is known as the mPTP. If the pore opens after reperfusion, this causes widespread depolarisation of the mitochondrial membrane potential, hydrolysis of ATP and mitochondrial disruption. Depending upon the redox state of the cell, this leads to mitochondria swelling and either apoptosis or necrotic cell death. The key to cell survival is therefore maintenance of the mPTP in a closed state during ischaemia-reperfusion and both volatile anaesthetics as well as propofol have been shown to reduce cell damage associated with mPTP opening. On a biochemical level, this protection is similar in magnitude to ischaemic preconditioning. Volatile anaesthetics enhance mPTP closure by enhancement of signaling ROS as well as RISK-SAFE pathway activation. During reperfusion, bursts of cytotoxic ROS lead to widespread opening of the mPTP and in these situations propofol is believed to help maintain mPTP closure by scavenging ROS. Although propofol possess potent ROS scavenging properties in vitro, questions remain as to whether this mechanism is primarily responsible for closing the mPTP and the associated reduction in cell injury seen clinically with propofol. For both volatiles and propofol, clinical studies have looked at biochemical markers, ventricular function and clinical outcomes predominantly relating to cardiovascular and neurological systems. While evidence is strong for in vitro and in vivo animal studies, clinical studies are more variable in effect but do point towards protective effects seen with both classes of agents. Manipulation of mPTP function offers a novel means of preventing ischaemic cell injury and anaesthetic agents occupy a unique niche in the pharmacological armamentarium available for use in preventing cell death following ischaemia-reperfusion injury.
